investorscraft@gmail.com

Intrinsic ValueBaWang International (Group) Holding Limited (1338.HK)

Previous CloseHK$0.04
Intrinsic Value
Upside potential
Previous Close
HK$0.04

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

BaWang International (Group) Holding Limited operates within the consumer defensive sector, specifically the household and personal products industry. The company's core revenue model is centered on the design, manufacture, and distribution of Chinese herbal-based personal care items, including shampoos, skin-care products, and household cleaners. It markets these under established brands such as Bawang, Royal Wind, Herborn, and Litao, leveraging a multi-channel distribution network that encompasses both traditional retailers and online platforms to reach a broad consumer base across China and select Southeast Asian markets. Its strategic positioning capitalizes on the growing consumer preference for natural and herbal ingredients in daily care routines, targeting a value-conscious segment. While it holds a recognized brand name, it operates in a highly competitive landscape dominated by larger multinational corporations, requiring a focus on regional strength and brand heritage to maintain its market niche.

Revenue Profitability And Efficiency

For the fiscal year, the company generated HKD 253.0 million in revenue. Profitability was modest, with net income of HKD 6.6 million, indicating thin margins. Operating cash flow of HKD 31.2 million was significantly stronger than net income, suggesting reasonable cash conversion efficiency from its core operations during the period.

Earnings Power And Capital Efficiency

The company's diluted earnings per share stood at HKD 0.0021, reflecting its modest earnings power. Capital expenditures of HKD -18.9 million indicate a net outflow for investments, which, when compared to its operating cash flow, shows a disciplined approach to reinvesting in its business while maintaining positive free cash flow generation.

Balance Sheet And Financial Health

The balance sheet exhibits a strong liquidity position with cash and equivalents of HKD 120.3 million, substantially exceeding its total debt of HKD 15.9 million. This low leverage and high cash balance provide a robust financial cushion and significant flexibility for navigating market conditions or pursuing strategic initiatives.

Growth Trends And Dividend Policy

The company did not pay a dividend for the period, indicating a retention of all earnings. This policy aligns with a focus on reinvesting capital back into the business to potentially fund future growth initiatives or strengthen its operational footprint, rather than providing immediate shareholder returns via distributions.

Valuation And Market Expectations

With a market capitalization of approximately HKD 155.0 million, the market values the company at a significant discount to its annual revenue. A beta of 0.223 suggests the stock has historically been far less volatile than the broader market, potentially reflecting its small size and niche market positioning.

Strategic Advantages And Outlook

The company's key advantages include its established herbal product heritage and brand recognition in its core markets. Its outlook is tied to its ability to compete effectively against larger players and potentially expand its product portfolio or geographic reach, supported by its strong, debt-light balance sheet providing operational stability.

Sources

Company Annual ReportHong Kong Stock Exchange Filings

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount